Management algorithm for subclinical hypoxemia in coronavirus disease-2019 patients: Intercepting the "Silent Killer"

The presence of asymptomatic hypoxemia (AH) in patients with coronavirus disease (COVID-19) is well described.[1] AH is thought to be responsible for the phenomenon of rapid clinical deterioration and mortality in the hospital setting,[2] and is frequently associated with the delayed escalation of c...

Full description

Saved in:
Bibliographic Details
Published in:Journal of emergencies, trauma and shock trauma and shock, 2020-04, Vol.13 (2), p.110-113
Main Authors: Galwankar, Sagar, Paladino, Lorenzo, Gaieski, David, Nanayakkara, K, Somma, Salvatore, Grover, Joydeep, Stawicki, Stanislaw
Format: Article
Language:English
Subjects:
Algorithms
Anoxemia
Asymptomatic
China
Clinical deterioration
Coronavirus infections
Coronaviruses
COVID-19
Expert
Health aspects
Hemodynamics
Hospital patients
Hypoxemia
Medical imaging
Mortality
Oxygen
Point of care testing
Severe acute respiratory syndrome coronavirus 2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The presence of asymptomatic hypoxemia (AH) in patients with coronavirus disease (COVID-19) is well described.[1] AH is thought to be responsible for the phenomenon of rapid clinical deterioration and mortality in the hospital setting,[2] and is frequently associated with the delayed escalation of care.[3] In addition, at-home mortality is thought to be elevated among those with AH who are discharged from the emergency department following an apparently low-acuity ambulatory evaluation.[4],[5] Such patients may have profound hypoxemia without significant dyspnea, with the initial sign of deterioration being confined to escalating oxygen requirement.[5]
ISSN:0974-2700
0974-519X
DOI:10.4103/JETS.JETS_72_20